These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22207003)

  • 1. Apoptosis markers soluble Fas (sFas), Fas Ligand (FasL) and sFas/FasL ratio in patients with bacteremia: a prospective cohort study.
    Huttunen R; Syrjänen J; Vuento R; Laine J; Hurme M; Aittoniemi J
    J Infect; 2012 Mar; 64(3):276-81. PubMed ID: 22207003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating soluble Fas concentration in breast cancer patients.
    Ueno T; Toi M; Tominaga T
    Clin Cancer Res; 1999 Nov; 5(11):3529-33. PubMed ID: 10589768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum sFas/sFasL ratio in systemic lupus erythematosus (SLE) is a function of age.
    Turi MC; D'Urbano M; Celletti E; Alessandri C; Valesini G; Paganelli R
    Arch Gerontol Geriatr; 2009; 49 Suppl 1():221-6. PubMed ID: 19836636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble Fas and soluble Fas-ligand in children with Escherichia coli O157:H7-associated hemolytic uremic syndrome.
    Masri C; Proulx F; Toledano B; Clermont MJ; Mariscalco MM; Seidman EG; Carcillo J
    Am J Kidney Dis; 2000 Oct; 36(4):687-94. PubMed ID: 11007669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble Fas, Fas ligand and Bcl-2 in autoimmune thyroid diseases: relation to humoral immune response markers.
    Myśliwiec J; Okota M; Nikołajuk A; Górska M
    Adv Med Sci; 2006; 51():119-22. PubMed ID: 17357290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble Fas and soluble Fas ligand levels in patients with acute hepatic failure.
    Nakae H; Narita K; Endo S
    J Crit Care; 2001 Jun; 16(2):59-63. PubMed ID: 11481600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High soluble Fas and soluble Fas Ligand serum levels before stent implantation are protective against restenosis.
    Katsaros KM; Wiesbauer F; Speidl WS; Kastl SP; Huber K; Zorn G; Niessner A; Glogar D; Maurer G; Wojta J
    Thromb Haemost; 2011 May; 105(5):883-91. PubMed ID: 21359408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAS/FAS ligand ratio: a marker of oxaliplatin-based intrinsic and acquired resistance in advanced colorectal cancer.
    Nadal C; Maurel J; Gallego R; Castells A; Longarón R; Marmol M; Sanz S; Molina R; Martin-Richard M; Gascón P
    Clin Cancer Res; 2005 Jul; 11(13):4770-4. PubMed ID: 16000573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble Fas and Fas ligand provide new information on metastasis and response to chemotherapy in SCLC patients.
    Shimizu M; Kondo M; Ito Y; Kume H; Suzuki R; Yamaki K
    Cancer Detect Prev; 2005; 29(2):175-80. PubMed ID: 15829378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure.
    Perianayagam MC; Murray SL; Balakrishnan VS; Guo D; King AJ; Pereira BJ; Jaber BL
    J Lab Clin Med; 2000 Oct; 136(4):320-7. PubMed ID: 11039853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble Fas is a marker of coronary artery disease in patients with end-stage renal disease.
    Hébert MJ; Masse M; Vigneault N; Sirois I; Troyanov S; Madore F
    Am J Kidney Dis; 2001 Dec; 38(6):1271-6. PubMed ID: 11728960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment.
    Tinazzi E; Puccetti A; Gerli R; Rigo A; Migliorini P; Simeoni S; Beri R; Dolcino M; Martinelli N; Corrocher R; Lunardi C
    Int Immunol; 2009 Mar; 21(3):237-43. PubMed ID: 19181929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of soluble fas and soluble fas ligand in serum of patients with complete hydatidiform moles.
    Soni S; Rath G; Deval R; Salhan S; Mishra AK; Saxena S
    Am J Reprod Immunol; 2011 Sep; 66(3):230-6. PubMed ID: 21385271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of apoptotic markers among human immunodeficiency virus (HIV-1) infected individuals.
    Ramalingam S; Kannangai R; Abraham OC; Subramanian S; Rupali P; Pulimood SA; Jesudason MV; Sridharan G
    Indian J Med Res; 2008 Dec; 128(6):728-33. PubMed ID: 19246796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sFas/sFasL ratio as a novel marker of inflammation in children with chronic kidney disease.
    Musiał K; Zwolińska D
    Clin Chim Acta; 2012 Dec; 414():7-11. PubMed ID: 22898262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation of soluble Fas and soluble Fas ligand levels of bronchoalveolar lavage fluid in lung cancer patients.
    Erdoğan B; Uzaslan E; Budak F; Karadağ M; Ediger D; Oral B; Göral G; Ege E; Gözü O
    Tuberk Toraks; 2005; 53(2):127-31. PubMed ID: 16100648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of apoptosis markers in advanced heart failure patients.
    Niessner A; Hohensinner PJ; Rychli K; Neuhold S; Zorn G; Richter B; Hülsmann M; Berger R; Mörtl D; Huber K; Wojta J; Pacher R
    Eur Heart J; 2009 Apr; 30(7):789-96. PubMed ID: 19196721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of Fas and Fas ligand in tuberculous lymphadenitis.
    Mustafa T; Mogga SJ; Mfinanga SG; Mørkve O; Sviland L
    Immunology; 2005 Feb; 114(2):255-62. PubMed ID: 15667570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble Fas (sFas) and soluble Fas ligand (sFas-L) balance in laryngeal carcinoma before and after surgical treatment.
    Pignataro L; Arisi E; Sambataro G; Corsi MM
    J Surg Oncol; 2003 Jun; 83(2):112-5. PubMed ID: 12772205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fas and Fas ligand: Expression and soluble circulating levels in bile duct carcinoma.
    Murakami M; Sasaki T; Miyata H; Yamasaki S; Kuwahara K; Chayama K
    Oncol Rep; 2004 Jun; 11(6):1183-6. PubMed ID: 15138553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.